Analysis, Bioservo: Bright future ahead

Despite a lower sales than expected in the third quarter the future is bright. The company has improved its financial position after the end of the quarter. Due to a larger dilution we lower our target price in our basescenario to 27,7 kronor per share.

Read the full report here. (Swedish)